0001567619-22-006233.txt : 20220303 0001567619-22-006233.hdr.sgml : 20220303 20220303162540 ACCESSION NUMBER: 0001567619-22-006233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Xiaolin CENTRAL INDEX KEY: 0001849181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 22709186 MAIL ADDRESS: STREET 1: C/O REVOLUTION MEDICINES, INC. STREET 2: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2022-03-01 0 0001628171 Revolution Medicines, Inc. RVMD 0001849181 Wang Xiaolin C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063 0 1 0 0 See Remarks Common Stock 2022-03-01 4 A 0 20000 0 A 31938 D Stock Option (Right to Buy) 18.56 2022-03-01 4 A 0 70000 0.00 A 2032-02-29 Common Stock 70000 70000 D Includes 29,100 Restricted Stock Units. One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. EVP, Clinical Development /s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang 2022-03-03